Wordt geladen...
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...
Bewaard in:
| Gepubliceerd in: | Allergy Asthma Clin Immunol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363352/ https://ncbi.nlm.nih.gov/pubmed/25788949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-55 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|